Abstract:Background: Pneumonia is an infection of the pulmonary parenchyma, causing significant morbidity and mortality. Inflammation potentiates hypoalbuminemia. CRP is an acute phase reactant produced by the liver in response to inflammation, which depends on severity of illness. Serum albumin concentration as a negative acute phase reactant, changes with change in CRP(C-reactive protein) value. Objectives: To study the prognostic significance of commonly used biomarkers serum Albumin level and C - reactive protein in hospitalized patients with Community Acquired Pneumonia. Methodology: The prospective study was conducted in a hospital affiliated to Vijayanagara Institute of Medical Science, Ballari. Patients with signs and symptoms of CAP were hospitalized based on a CURB-65 score. After informed consent, all relevant data was collected. Clinical examination and laboratory parameters i.e. Serum albumin & C - reactive protein levels on day 1, 3 & 7/discharge were carried out. The values of serum albumin & C - reactive protein were analyzed with the clinical profile and outcome in these study groups. Results: In our study, CAP was more commonly seen among the age group of 61-70 yrs (27%). COPD was a major associated co-morbidity (50%) and smoking was an important risk factor (70%). The majority had a CURB 65 score of >3-5 on admission (64%). Out of 50 patients, 26% of them had severe hypoalbuminemia (<2.5 mg/dl) and 58% of them had mild hypoalbuminemia (2.5-3.5 mg/dl) on day 1 of admission. When serum albumin levels at the time of admission were analyzed for the time of discharge, there was significant change (P=0.025) noted, i.e an increase in serum albumin levels were seen in all patients who had clinical signs of resolution. 38% of patients had serum CRP levels 200 mg/l. There was decrease in CRP level at the time of discharge (p=0.001). Serum Albumin levels and CRP levels showed significant change from day 1 to the day of discharge (p=0.025 and P=<0.001) respectively. ICU requirement, need for mechanical ventilation and other outcomes correlated well with serum albumin levels (p=0.021, p=0.004, p=0.003 respectively). Conclusion: Our study showed a history of smoking, COPD and hypoalbuminemia at presentation were major risk factors present for CAP. Patients with severe hypoalbuminemia had high morbidity and mortality in the form of ICU requirement, need for mechanical ventilation, complications and death. CRP serves as an important marker of inflammation whose series levels reduce significantly with cure / resolution of pneumonia. Thus, serum albumin levels and C reactive protein can be used as a prognostic biomarker in community acquired pneumonia.

Serum activin A as a prognostic biomarker for community acquired pneumonia

N-Myc and STAT Interactor is a Novel Biomarker of Severity in Community-Acquired Pneumonia: A Cohort Study

N-myc and STAT interactor is a novel biomarker of severity in community-acquired pneumonia: a prospective study

Serum Procalcitonin, White Blood Cell and Hypersensitive C-reactive Protein Combined with Age Established a New Prediction Model in Predicting ICU Admission in Adult Community-Acquired Pneumonia (CAP) Patients.

Clinical characteristics analysis and predictive diagnostic model building of community-acquired pneumonia in adults requiring hospitalisation in Fujian Provincial Hospital

Increased plasma AACT level as an indicator of poor prognosis in patients hospitalised with community-acquired pneumonia: a multicentre prospective cohort study

Clinical Characteristics Analysis and Construction of a Predictive Diagnostic Model of Community-Acquired Pneumonia in Adults Requiring Hospitalization in Fujian Provincial Hospital

Serum interleukin-17 predicts severity and prognosis in patients with community acquired pneumonia: a prospective cohort study

Decreased plasma fetuin-A level as a novel bioindicator of poor prognosis in community-acquired pneumonia: A multi-center cohort study

Change of Activin A in Cerebrospinal Fluid of Neonates with Bacterial Meningitis and Its Value for Prognosis Evaluation

The Prognostic Value of Serum Albumin Levels and Respiratory Rate for Community-Acquired Pneumonia: A Prospective, Multi-Center Study.

Activin A as a potential biomarker for preserved ratio impaired spirometry (PRISm) and clinical outcomes in community-dwelling adults

Neutrophil-to-Lymphocyte Ratio Improves the Accuracy and Sensitivity of Pneumonia Severity Index in Predicting 30-Day Mortality of CAP Patients

Associations of Serum Resistin With the Severity and Prognosis in Patients With Community-Acquired Pneumonia

Serum suPAR and syndecan-4 levels predict severity of community-acquired pneumonia: a prospective, multi-centre study

The moderate predictive value of serial serum CRP and PCT levels for the prognosis of hospitalized community-acquired pneumonia

Elevated Progranulin As a Novel Biomarker to Predict Poor Prognosis in Community-Acquired Pneumonia

The associations of serum S100A9 with the severity and prognosis in patients with community-acquired pneumonia: a prospective cohort study

Serum Albumin And C-reactive Protein as Prognostic Biomarkers in Hospitalised Patients with Community Acquired Pneumonia

Mortality prediction using serum biomarkers and various clinical risk scales in community-acquired pneumonia

Predictive value of community-acquired pneumonia severity scores on lung cancer patients with immune checkpoint inhibitor-associated pneumonitis: a retrospective analysis